Inhibitory effect of Agrimoniae Herba on lipopolysaccharide-induced nitric oxide and proinflammatory cytokine production in BV2 microglial cells. 2010

Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Korea.

OBJECTIVE Agrimoniae Herba has been used as an anti-inflammatory agent in traditional medicine. Nitric oxide and proinflammatory cytokines produced by activated microglia may be a possible etiological factor of neurodegenerative disorders. We evaluated whether Agrimoniae Herba could have an anti-inflammatory effect on lipopolysaccharide-induced BV2 microglial cells. METHODS The effects of Agrimoniae Herba on lipopolysaccharide-induced nitric oxide and proinflammatory cytokine production in BV2 microglial cells were evaluated by nitric oxide assay, enzyme-linked immunosorbent assay and western blotting. RESULTS Agrimoniae Herba had no cytotoxicity and suppressed lipopolysaccharide-induced nitric oxide production in BV2 microglial cells. Agrimoniae Herba also suppressed lipopolysaccharide-induced production of proinflammatory cytokines such as tumor necrosis factor, interleukin 1 beta and interleukin 6 in a dose-dependent manner. Agrimoniae Herba inhibited the expression of inducible nitric oxide synthase. CONCLUSIONS Taken together, these findings indicate that Agrimoniae Herba may be used as a form of pharmaceutical acupuncture therapy in the treatment of brain inflammation.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D004610 Ellagic Acid A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye. Benzoaric Acid,Acid, Benzoaric,Acid, Ellagic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
March 2004, Archives of pharmacal research,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
July 2007, Planta medica,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
December 2014, Bioorganic & medicinal chemistry letters,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
October 2002, The European journal of neuroscience,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
November 2015, Biochemical and biophysical research communications,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
July 2010, Planta medica,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
January 2011, Cellular immunology,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
October 2015, Toxicology and industrial health,
Hyunsu Bae, and Hye-Jeoung Kim, and Minkyu Shin, and Hyejung Lee, and Chang Shik Yin, and Jehyeon Ra, and Jinju Kim
June 2008, Planta medica,
Copied contents to your clipboard!